Philip Scheltens Selected Research

Philip Scheltens Research Topics

Disease

336	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 08/2002
187	Dementia (Dementias) 04/2024 - 09/2003
167	Cognitive Dysfunction 03/2024 - 03/2002
85	Atrophy 11/2023 - 03/2002
26	Disease Progression 01/2023 - 06/2012
20	Frontotemporal Dementia (Semantic Dementia) 07/2023 - 09/2003
13	Amyloid Plaque 11/2023 - 01/2011
11	Inflammation (Inflammations) 04/2024 - 08/2002
11	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2023 - 09/2003
8	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2018 - 01/2003
6	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2015
6	Genetic Risk Score 12/2022 - 01/2016
5	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2023 - 11/2009
5	Amyloidosis 06/2022 - 03/2013
5	Hypertension (High Blood Pressure) 01/2010 - 07/2004
4	Tauopathies 01/2023 - 09/2003
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2006
4	Memory Disorders (Memory Loss) 01/2021 - 01/2006
4	Pathologic Processes 10/2020 - 12/2004
4	Infarction (Infarctions) 01/2019 - 01/2007
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2023 - 11/2013
3	Lewy Body Disease (Lewy Body Dementia) 08/2023 - 07/2013
3	Synucleinopathies 08/2023 - 01/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2009
3	Cerebrovascular Trauma 01/2022 - 01/2019
3	Multiple Sclerosis 06/2021 - 01/2017
3	Breast Neoplasms (Breast Cancer) 06/2021 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 06/2021 - 01/2018
3	Neurobehavioral Manifestations 01/2018 - 12/2011
3	Edema (Dropsy) 01/2018 - 07/2011
3	Cerebral Small Vessel Diseases 01/2015 - 10/2012
2	Neurocognitive Disorders (Clerambault Syndrome) 03/2024 - 01/2023
2	Cerebral Infarction 11/2023 - 09/2013
2	Mental Disorders (Mental Disorder) 07/2023 - 01/2016
2	Infections 01/2022 - 04/2010
2	Myocardial Infarction 06/2021 - 01/2019
2	Sepsis (Septicemia) 06/2021 - 01/2019
2	Malnutrition (Nutritional Deficiencies) 01/2020 - 05/2019
2	Primary Progressive Aphasia 01/2020 - 11/2018
2	Vascular Diseases (Vascular Disease) 01/2020 - 01/2006
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 12/2015
2	Neoplasms (Cancer) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

217	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2003
183	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2006
62	Apolipoproteins E (ApoE)IBA 01/2024 - 03/2002
38	Pemetrexed (MTA)FDA Link 01/2023 - 07/2004
32	Amyloid beta-PeptidesIBA 03/2024 - 07/2005
27	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2006
25	ApolipoproteinsIBA 01/2024 - 03/2002
13	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 11/2023 - 12/2017
13	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2006
9	Threonine (L-Threonine)FDA Link 01/2022 - 01/2010
9	Peptides (Polypeptides)IBA 06/2021 - 09/2013
8	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2019 - 08/2010
7	flutemetamolIBA 04/2024 - 01/2017
7	Cholinergic Agents (Cholinergics)IBA 01/2022 - 12/2004
6	Retinaldehyde (Retinal)IBA 08/2023 - 01/2018
6	Blood Proteins (Serum Proteins)IBA 01/2021 - 01/2018
6	EnzymesIBA 01/2020 - 11/2009
5	Galantamine (Galanthamine)FDA LinkGeneric 01/2022 - 01/2006
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 01/2006
5	NeurograninIBA 10/2021 - 10/2015
4	florbetapirIBA 04/2024 - 01/2019
4	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 04/2024 - 01/2018
4	tau Proteins (tau Protein)IBA 10/2023 - 09/2003
4	Glial Fibrillary Acidic ProteinIBA 01/2023 - 01/2020
4	Memantine (Namenda)FDA Link 10/2021 - 01/2004
4	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2014
4	Phosphotransferases (Kinase)IBA 01/2021 - 07/2014
4	HomocysteineIBA 10/2020 - 06/2007
4	ImmunosorbentsIBA 01/2019 - 11/2009
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2012 - 01/2012
3	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 03/2024 - 01/2019
3	SynucleinsIBA 08/2023 - 01/2010
3	Indicators and Reagents (Reagents)IBA 01/2023 - 07/2013
3	Apolipoprotein E4IBA 01/2023 - 08/2002
3	IceIBA 06/2021 - 01/2018
3	HDL LipoproteinsIBA 01/2021 - 05/2008
3	Folic Acid (Vitamin M)FDA LinkGeneric 10/2020 - 01/2015
3	IronIBA 10/2020 - 12/2007
3	UridineIBA 01/2020 - 01/2015
3	Antihypertensive Agents (Antihypertensives)IBA 01/2015 - 01/2006
3	PK 11195 (PK11195)IBA 01/2013 - 09/2007
3	Verapamil (Calan)FDA LinkGeneric 10/2012 - 01/2012
3	2- (1- (6- ((2- fluoroethyl)(methyl)amino)- 2- naphthyl)ethylidene)malononitrileIBA 06/2012 - 02/2009
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2023 - 01/2008
2	EpitopesIBA 01/2023 - 01/2018
2	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 11/2022 - 01/2020
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 01/2020
2	Chitinase-3-Like Protein 1IBA 10/2021 - 09/2015
2	Triglycerides (Triacylglycerol)IBA 10/2020 - 05/2008
2	VitaminsIBA 10/2020 - 01/2015
2	LipidsIBA 10/2020 - 01/2014
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2019

Therapy/Procedure

14	Activities of Daily Living (ADL) 01/2021 - 01/2010
12	Therapeutics 01/2021 - 07/2004
9	Institutionalization (Institutionalized Persons) 01/2022 - 01/2012
7	Secondary Prevention 10/2020 - 04/2006
3	Home Nursing (Nursing, Home) 05/2015 - 01/2005
2	Precision Medicine 11/2019 - 12/2018